Emre Yucel, PhD, MPE, MS, MIBS, Pharm, is a results-driven Senior Director of Health Economics and Outcomes Research (HEOR) with over 8 years of experience in the pharmaceutical industry. Currently leading HEOR efforts at Merck, he specializes in Real-World Evidence (RWE) strategies, patient-reported outcomes, and economic modeling. Emre has a proven track record of cross-functional leadership, evidence generation, and global collaboration to support market access, reimbursement, and clinical decision-making. Prior to Merck, he served as Director of WW HEOR-Hematology at Bristol Myers Squibb, focusing on CAR T therapies, and as a Manager at Amgen, leading statistical analysis for patient-reported outcomes. Emre’s academic background includes a PhD in Epidemiology, an MPE in Pharmacoeconomics and Epidemiology, and an MS in Clinical Pharmacy/Pharmacology. His research and leadership have significantly contributed to the development of value-based assessments and market access strategies for pharmaceutical products.